Search
  • Search

    HUS 080-2024 Genetic testing for rare diseases, various methods

    HUS-yhtymä

    HUS 080-2024 Genetic testing for rare diseases, various methods

    1. Competition notice published

      Jan 15, 2025 1:31 PMJanuary 15, 2025 1:31 PM

    2. Supplier selection

      Jul 11, 2025 12:00 AMJuly 11, 2025 12:00 AM

    3. Contract signed

      Oct 8, 2025 12:00 AMOctober 8, 2025 12:00 AM

    4. Result notice published

      Nov 10, 2025 10:56 AMNovember 10, 2025 10:56 AM

    Brief

    Finland: Tenders/HUS-yhtymä/HUS 080-2024 Genetic testing for rare diseases, various methods

    Awarded

    The competition has ended and a winner has been selected.

    Brief

    Helse- og sosial tjenesteyting

    HUS-yhtymä has entered into an agreement with Centogene GmbH and MVZ Martinsried GmbH for genetic testing for rare diseases using various methods. The services include 20 different genetic tests, such as Ataxia repeat analysis, repeat expansion analysis, genetic testing for hereditary Alpha Tryptasemia, MLH1 promoter methylation analysis, Beckwith-Wiedemann syndrome testing, Cystic fibrosis (CF-EU2), Long-range PCR analysis of CYP21A2, PKD1, PKD2, PMS2, SBDS, genetic testing for facioscapulohumeral muscular dystrophy (FSHD1 and FSHD2), Chromosomal breakage test (Fanconi anemia), Relative telomere length analysis, X inactivation test, genetic testing for haemoglobinopathies, Germline episignature, DNA methylation pattern testing for specific genetic disorders, Sanger sequencing/ Long-range PCR analysis of the VWF gene, and Retinoblastoma genetic screening. The total value of the contract is 1,100,000 €. Two bids were received for this procurement.

    Result

    Winners
    • CENTOGENE GmbH
    • MVZ Martinsried GmbH
    Number of bids
    2
    Contract value
    €1,100,000

    About the bid

      The Procurement Entities HUS Group (later also ”HUS”) and ISLAB requested tenders for genetic testing for rare diseases using various methods. The procurement included the following tests: 1. Ataxia repeat analysis by NGS 2. Repeat expansion analysis (UGT1A1) 3. Repeat expansion analysis (CANVAS) 4. Repeat expansion analysis (MUC1) 5. Genetic testing for hereditary Alpha Tryptasemia 6. MLH1 promoter methylation analysis 7. Beckwith-Wiedemann syndrome testing 8. Cystic fibrosis (CF-EU2) 9. Long-range PCR analysis of CYP21A2 10. Long-range PCR analysis of PKD1 and PKD2 11. Long-range PCR analysis of PMS2 12. Long-range PCR analysis of SBDS 13. Genetic testing for facioscapulohumeral muscular dystrophy (FSHD1 and FSHD2) 14. Chromosomal breakage test (Fanconi anemia) 15. Relative telomere length analysis 16. X inactivation test 17. Genetic testing for haemoglobinopathies 18. Germline episignature, DNA methylation pattern testing for specific genetic disorders 19. Sanger sequencing/ Long-range PCR analysis of the VWF gene 20. Retinoblastoma genetic screening. The procurement was divided into lots so that each test was an independent part of the procurement. An agreement was made with each selected service provider, which included the services for which the service provider had been selected as the supplier.Main features of the procedureThe procurement procedure is an open procedure in accordance with Section 109 of the Finnish Act on Public Procurement and Concession Contracts (1397/2016, "Procurement Act"), where any tenderer can participate in. Section 96 of the Procurement Act regarding abnormally low tenders applies to this procurement. The procedure is as follows: Procurement Entity will: 1. open tenders 2. verify answers given to the suitability requirements 3. verify tender's compliance with call for tenders After that, the Procurement Entity may 4A. conduct a tender comparison, or 4B. proceed to the negotiation procedure. The negotiation procedure may be proceeded to if: A. no tenders have been received in the tender in accordance with the call for tenders; B. no tenders can be accepted due to too high a price or other reason; or C. the Procurement Entity deems it necessary to negotiate the details of the tenders. The Procurement Entity may decide to proceed to the negotiation procedure with one, several or all sub-areas of the procurement. In other sub-areas the comparison of tenders is conducted on the base of the original tenders. All tenderers who have submitted a tender by the deadline and who meet the conditions regarding the suitability of the tenderer described in this call for tenders will be invited to the negotiations. The aim of the negotiations is to update the original call for tenders so that the tenderers selected for the negotiations can submit new tenders based on it. The negotiations will be conducted equally with all invited tenderers for a period determined by the Procurement Entity. After the negotiations, the Procurement Entity will submit an updated call for tenders to all tenderers who participated in the negotiations, on the basis of which the tenderers will submit new tenders. After this, the procurement procedure continues from point 1 described above based on the new call for tenders. After the tender comparison has been conducted, the Procurement Entity will: 5. request the winning tenderers to submit reports and other documents related to the suitability requirements 6. make a procurement decision 8. sign agreements with the chosen tenderers.

      Contact name
      Arttu Karjalainen
      Contact phone
      +358 503549873
      Contact email
      mons.vermis@gmail.com
      Address
      Uutistie 5, 01770 Vantaa

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

    • Description

      Comparison price is the price of the analysis.

    • Description

      If the test is accredited, the tenderer will receive the maximum score (40 points) in quality comparison of this sub-area. If the test is not accredited, the tenderer will receive zero (0) points.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    HUS-yhtymä
    Title
    HUS 080-2024 Genetic testing for rare diseases, various methods
    Type
    ResultPrequalification
    Main code
    85145000Services provided by medical laboratories
    Supplemental codes

    No supplemental codes from buyer…

    Active similar competitions

    • HUS-yhtymä

      Helse- og sosial tjenesteyting

      HUS Subcontracting genetic diagnostic tests

      HUS Group needs genetic diagnostic test services to support clinical patient work and individual patient treatment decisions. These services are for various clinics within the HUS Joint Municipal Authority for Specialised Health Care, and also for ISLAB (Eastern Finland Laboratory Centre, Joint Authority Enterprise). The services are procured through a dynamic purchasing system. Suppliers must have a yearly turnover of at least EUR 500,000, a risk category of RL1-RL3, professional experience with similar genetic diagnostic test services for reference customers during the last three years, and the laboratory must have accreditation status secured for at least two years. Additionally, candidates must have experience in supplying at least 5000 genetic studies yearly for university-level or similar hospitals within the EU/EEA area. Award criteria for specific competitions will be based on overall financial affordability, which may include price and/or quality.

      Dynamic purchasing systemMar 24, 2025
      May 9, 2030(100+ days)

    • HUS-yhtymä

      Laboratorie- og analyseutstyr

      MLPA-Based CNV Testing for BRCA1/BRCA2

      HUS Group, the joint authority for Helsinki and Uusimaa, needs an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licenses, and other components required for routine use and generation of reportable patient results. The contract period is 2 years, after which it continues indefinitely until terminated. The estimated annual consumption is approximately 1600 reportable patient samples, to be delivered to the HUSLAB Laboratory of Genetics in Helsinki-Uusimaa, Finland. The award criterion is the lowest total comparison price.

      CompetitionOct 7, 2026
      Nov 9, 2026(11 days)

    • HUS-yhtymä

      Laboratorie-kits og reagenser

      Automaattinen nukleiinihappojen eristyslaite

      HUS-yhtymä suunnittelee automaattisen nukleiinihappojen eristyslaitteen hankintaa HUS Diagnostiikkakeskuksen Kliinisen mikrobiologian nukleiinihappoanalytiikkaan, sisältäen laitteen, varalaitteen tai kaksi erillistä eristysmoduulia sekä tarvittavat reagenssit ja tarvikkeet. Hankittavalla laitteella on tarkoitus eristää bakteeri-DNA:ta useista eri näytemateriaaleista, ja eristetyn tuotteen tulee olla validoitu bakteerien 16S-geenin PCR-monistamiseen Sanger-sekvensoinnilla. Toimittajia pyydetään tutustumaan liitteenä oleviin kysymyksiin ja toimittamaan vastaukset sähköpostitse osoitteeseen kilpailutus.diagnostiikka@hus.fi. bioMérieux Suomi OY:llä on todennäköisesti sopimus tällä hetkellä.

      PlanningSep 16, 2026
      Jan 16, 2027(79 days)

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      PlanningAug 18, 2026
      Nov 1, 2026(3 days)

    • Varsinais-Suomen hyvinvointialue

      Helse- og sosial tjenesteyting

      Laboratoriotutkimuspalvelut

      Varsinais-Suomen hyvinvointialue tarvitsee laboratoriotutkimuspalveluita, joiden kokonaisarvo on enintään 4,04 miljoonaa euroa. Tarjoukset käsitellään kolmessa vaiheessa: tarjoajien soveltuvuuden arviointi, tarjousten tarjouspyynnön mukaisuuden arviointi ja tarjousten kokonaistaloudellisuuden vertailu. Tarjoukset arvioidaan halvimman hinnan perusteella. Tarjoajien on laadittava tarjoukset suomen kielellä.

      CompetitionOct 22, 2026
      Nov 26, 2026(28 days)
      €4,040,000